156 related articles for article (PubMed ID: 30558027)
1. Complete remission of both immunoglobulin light chain amyloidosis and psoriasis after autologous hematopoietic stem cell transplantation: A case report.
Chen W; Ren G; Zuo K; Huang X
Medicine (Baltimore); 2018 Dec; 97(50):e13589. PubMed ID: 30558027
[TBL] [Abstract][Full Text] [Related]
2. Risk factors, treatments and outcomes of patients with light chain amyloidosis who relapse after autologous stem cell transplantation.
Zhang Y; Guo J; Chen W; Zhao L; Huang X
Bone Marrow Transplant; 2024 Mar; 59(3):350-358. PubMed ID: 38148411
[TBL] [Abstract][Full Text] [Related]
3. Outcome of Patients with Immunoglobulin Light-Chain Amyloidosis with Lung, Liver, Gastrointestinal, Neurologic, and Soft Tissue Involvement after Autologous Hematopoietic Stem Cell Transplantation.
Afrough A; Saliba RM; Hamdi A; El Fakih R; Varma A; Dinh YT; Rondon G; Cornelison AM; Shah ND; Bashir Q; Shah JJ; Hosing C; Popat U; Orlowski RZ; Champlin RE; Parmar S; Qazilbash MH
Biol Blood Marrow Transplant; 2015 Aug; 21(8):1413-7. PubMed ID: 25842049
[TBL] [Abstract][Full Text] [Related]
4. New Light Chain Amyloid Response Criteria Help Risk Stratification of Patients by Day 100 after Autologous Hematopoietic Cell Transplantation.
D'Souza A; Huang J; Hari P
Biol Blood Marrow Transplant; 2016 Apr; 22(4):768-770. PubMed ID: 26743343
[TBL] [Abstract][Full Text] [Related]
5. Improved Outcomes After Autologous Hematopoietic Cell Transplantation for Light Chain Amyloidosis: A Center for International Blood and Marrow Transplant Research Study.
D'Souza A; Dispenzieri A; Wirk B; Zhang MJ; Huang J; Gertz MA; Kyle RA; Kumar S; Comenzo RL; Peter Gale R; Lazarus HM; Savani BN; Cornell RF; Weiss BM; Vogl DT; Freytes CO; Scott EC; Landau HJ; Moreb JS; Costa LJ; Ramanathan M; Callander NS; Kamble RT; Olsson RF; Ganguly S; Nishihori T; Kindwall-Keller TL; Wood WA; Mark TM; Hari P
J Clin Oncol; 2015 Nov; 33(32):3741-9. PubMed ID: 26371138
[TBL] [Abstract][Full Text] [Related]
6. Comprehensive Review of AL amyloidosis: some practical recommendations.
Al Hamed R; Bazarbachi AH; Bazarbachi A; Malard F; Harousseau JL; Mohty M
Blood Cancer J; 2021 May; 11(5):97. PubMed ID: 34006856
[TBL] [Abstract][Full Text] [Related]
7. High-dose melphalan and stem cell transplantation in systemic AL amyloidosis in the era of novel anti-plasma cell therapy: a comprehensive review.
Varga C; Comenzo RL
Bone Marrow Transplant; 2019 Apr; 54(4):508-518. PubMed ID: 30089901
[TBL] [Abstract][Full Text] [Related]
8. Haematologic responses and survival do not significantly decrease with subsequent lines of therapy in systemic immunoglobulin light chain amyloidosis: results from an analysis of real-world longitudinal data.
Ravichandran S; Cohen OC; Law S; Sachchithanantham S; Mahmood S; Foard D; Fontana M; Martinez-Naharro A; Whelan C; Gillmore JD; Lachmann HJ; Hawkins PN; Wechalekar AD
Br J Haematol; 2021 Aug; 194(3):587-597. PubMed ID: 34189728
[TBL] [Abstract][Full Text] [Related]
9. Orthotopic heart transplant facilitated autologous hematopoietic stem cell transplantation in light-chain amyloidosis.
Kamble RT
Methodist Debakey Cardiovasc J; 2012; 8(3):17-8. PubMed ID: 23227280
[TBL] [Abstract][Full Text] [Related]
10. AL Amyloidosis: The Effect of Maintenance Therapy on Autologous Stem Cell Transplantation Outcomes.
Ozga M; Zhao Q; Benson D; Elder P; Williams N; Bumma N; Rosko A; Chaudhry M; Khan A; Devarakonda S; Kahwash R; Vallakati A; Campbell C; Parikh SV; Almaani S; Prosek J; Bittengle J; Pfund K; LoRusso S; Freimer M; Redder E; Efebera Y; Sharma N
J Clin Med; 2020 Nov; 9(11):. PubMed ID: 33238501
[TBL] [Abstract][Full Text] [Related]
11. Autologous stem cell transplant for Al amyloidosis.
Roy V
Bone Marrow Res; 2012; 2012():238961. PubMed ID: 22675637
[TBL] [Abstract][Full Text] [Related]
12. Update on treatment of light chain amyloidosis.
Mahmood S; Palladini G; Sanchorawala V; Wechalekar A
Haematologica; 2014 Feb; 99(2):209-21. PubMed ID: 24497558
[TBL] [Abstract][Full Text] [Related]
13. Multiple myeloma complicated with light chain cast nephropathy with focal amyloidosis: A case report.
He Y; Hua Z; Tan H; Zhao C; Liu Q; Jia J; Gao Y
Nephrology (Carlton); 2024 May; ():. PubMed ID: 38741555
[TBL] [Abstract][Full Text] [Related]
14. Acute kidney injury during autologous stem cell transplantation in light chain amyloidosis with kidney involvement and their impact on prognosis.
Xu W; Chen W; Guo J; Zhao L; Ren G; Huang X
Bone Marrow Transplant; 2024 Apr; ():. PubMed ID: 38658659
[TBL] [Abstract][Full Text] [Related]
15. T cell landscape and dynamics in immunoglobulin light chain amyloidosis before and after daratumumab-based therapy.
Wang Y; Xu L; Zhao W; Chen X; Wen L; Duan W; Yu XJ; De Zhou F; Liu Y; Hao J; Huang X; Lu J; Ge Q
Clin Transl Med; 2021 Nov; 11(11):e582. PubMed ID: 34845849
[TBL] [Abstract][Full Text] [Related]
16. Novel Therapies in Light Chain Amyloidosis.
Milani P; Merlini G; Palladini G
Kidney Int Rep; 2018 May; 3(3):530-541. PubMed ID: 29854961
[TBL] [Abstract][Full Text] [Related]
17. Long-term reversibility of renal dysfunction associated to light chain deposition disease with bortezomib and dexamethasone and high dose therapy and autologous stem cell transplantation.
González-López TJ; Vázquez L; Flores T; San Miguel JF; García-Sanz R
Clin Pract; 2011 Sep; 1(4):e95. PubMed ID: 24765395
[TBL] [Abstract][Full Text] [Related]
18. Teclistamab in relapsed or refractory AL amyloidosis: a multinational retrospective case series.
Forgeard N; Elessa D; Carpinteiro A; Belhadj K; Minnema M; Roussel M; Huart A; Javaugue V; Pascal L; Royer B; Talbot A; Gounot R; Hegenbart U; Schonland S; Karlin L; Harel S; Kastritis E; Bridoux F; Jaccard A; Arnulf B
Blood; 2024 Feb; 143(8):734-737. PubMed ID: 38096365
[No Abstract] [Full Text] [Related]
19. Outcomes of Modified Mayo Stage IIIa and IIIb Cardiac Light-Chain Amyloidosis: Real-World Experience in Clinical Characteristics and Treatment-67 Patients Multicenter Analysis.
Charliński G; Steinhardt M; Rasche L; Gonzalez-Calle V; Peña C; Parmar H; Wiśniewska-Piąty K; Dávila Valls J; Olszewska-Szopa M; Usnarska-Zubkiewicz L; Gozzetti A; Ciofini S; Gentile M; Zamagni E; Kurlapski M; Legieć W; Vesole DH; Jurczyszyn A
Cancers (Basel); 2024 Apr; 16(8):. PubMed ID: 38672674
[TBL] [Abstract][Full Text] [Related]
20. Light Chain Amyloidosis.
Milani P; Merlini G; Palladini G
Mediterr J Hematol Infect Dis; 2018; 10(1):e2018022. PubMed ID: 29531659
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
